These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 22489793)
21. Involvement of IFNbeta on IFNgamma and nitric oxide (NO) production by bone marrow (BM) cells in response to lipopolysaccharide. Campillo JA; Peláez B; Angulo I; Bensussan A; Subiza JL Biomed Pharmacother; 2006 Nov; 60(9):541-7. PubMed ID: 16978828 [TBL] [Abstract][Full Text] [Related]
22. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy. Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710 [TBL] [Abstract][Full Text] [Related]
23. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease. Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671 [TBL] [Abstract][Full Text] [Related]
24. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. Kelso A J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells. Tamma SL; Sundaram SK; Lev M; Coico RF Biochem Biophys Res Commun; 1996 Mar; 220(3):916-21. PubMed ID: 8607867 [TBL] [Abstract][Full Text] [Related]
26. Aberrant recruitment and activation of T cells in diabetic nephropathy. Moon JY; Jeong KH; Lee TW; Ihm CG; Lim SJ; Lee SH Am J Nephrol; 2012; 35(2):164-74. PubMed ID: 22286547 [TBL] [Abstract][Full Text] [Related]
27. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8. Senaldi G; Shaklee CL; Mak TW; Ulich TR Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057 [TBL] [Abstract][Full Text] [Related]
28. Positive coping up- and down-regulates in vitro cytokine productions from T cells dependent on stress levels. Sakami S; Maeda M; Maruoka T; Nakata A; Komaki G; Kawamura N Psychother Psychosom; 2004; 73(4):243-51. PubMed ID: 15184719 [TBL] [Abstract][Full Text] [Related]
29. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages. Stefani MM; Müller I; Louis JA Eur J Immunol; 1994 Mar; 24(3):746-52. PubMed ID: 7510243 [TBL] [Abstract][Full Text] [Related]
30. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. Bank I; Duvdevani M; Livneh A J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166 [TBL] [Abstract][Full Text] [Related]
31. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762 [TBL] [Abstract][Full Text] [Related]
32. Effect of combined colchicine-corticosteroid treatment on neutrophil/lymphocyte ratio: a predictive marker in Behçet disease activity. Djaballah-Ider F; Touil-Boukoffa C Inflammopharmacology; 2020 Aug; 28(4):819-829. PubMed ID: 32227261 [TBL] [Abstract][Full Text] [Related]
33. [Reason for the damping effect of tumor cells on human T-lymphocytes]. Strelkov LA; Mikhaĭlova AA; Sapozhnikov AM; Petrov RV Dokl Akad Nauk; 1996 Mar; 347(2):278-80. PubMed ID: 8768094 [No Abstract] [Full Text] [Related]
34. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease. Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148 [TBL] [Abstract][Full Text] [Related]
35. Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment. Djaballah-Ider F; Djaballah A; Djeraba Z; Chaib S; Touil-Boukoffa C Inflammopharmacology; 2019 Dec; 27(6):1113-1122. PubMed ID: 30721371 [TBL] [Abstract][Full Text] [Related]
36. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease. Djaballah-Ider F; Djeraba Z; Chemli M; Dammene-Debbihe N; Lounis D; Belguendouz H; Medour Y; Chaib S; Touil-Boukoffa C Inflammopharmacology; 2018 Jun; 26(3):725-735. PubMed ID: 29600486 [TBL] [Abstract][Full Text] [Related]
37. Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism. Belguendouz H; Lahmar-Belguendouz K; Messaoudene D; Djeraba Z; Otmani F; Hakem D; Lahlou-Boukoffa OS; Youinou P; Touil-Boukoffa C Int J Inflam; 2015; 2015():241738. PubMed ID: 25692069 [TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of ocular Behçet's disease. Park UC; Kim TW; Yu HG J Immunol Res; 2014; 2014():653539. PubMed ID: 25061613 [TBL] [Abstract][Full Text] [Related]
39. T cells activation and interferon-γ/nitric oxide production during Behçet disease: a study in Algerian patients. Djaballah-Ider F; Chaib S; Belguendouz H; Talbi D; Touil-Boukoffa C Ocul Immunol Inflamm; 2012 Jun; 20(3):215-7. PubMed ID: 22489793 [TBL] [Abstract][Full Text] [Related]
40. Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10. Belguendouz H; Messaoudène D; Lahmar K; Ahmedi L; Medjeber O; Hartani D; Lahlou-Boukoffa O; Touil-Boukoffa C J Interferon Cytokine Res; 2011 Sep; 31(9):643-51. PubMed ID: 21510811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]